what are the differences between glp 1 medications GLP-1 receptor agonists GLP-1 Drug Comparison in Diabetes

Safety Issues When sources are doubtful, the quality of medications cannot be verified

Atomic coordinates have been deposited in the Protein Data Bank under the accession code 9MUN (GSSG-bound SLC33A1 MAP )

The cysteinyl thiol is a potent reducing agent, making GSH the most abundant antioxidant intracellular small molecule thiol

efocipegtrutide ( LAPS Triple agonist) efpegerglucagon ( LAPS Glucagon analog) HM97662 (EZH1/2 inhibitor) BH3120 (PD-L1/4-1BB BsAb) HM15275 (LA-GLP/GIP/GCG) HM16390 ( LAPS IL-2 analog) HM17321 (LA-UCN2) HM101207 (SOS1 inhibitor) LAPS Glucagon Combo HM15275 (LA-GLP/GIP/GCG) Overview As a long-acting glucagon-like peptide (GLP-1), gastric inhibitory peptide (GIP) and glucagon triple agonist, HM15275 achieves more favorable pharmacodynamics profile in addition to once-weekly dosing